
Company Info
Year Established2019
Contacts
Joel BarrishPresident & CEO
Effie Tozzo, PhD
CSO
Phil Graham, PhD
CDO
Adam Muzikant, PhD
CBO
Emilie Castonguay, PhD
Senior Director Strategy & Portfolio Development
Company Description
Avilar Therapeutics is a biopharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.